Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Int J Nanomedicine. 2020 Sep 29;15:7199-7214. doi: 10.2147/IJN.S270229. eCollection 2020.
The ongoing biomedical nanotechnology has intrigued increasingly intense interests in cerium oxide nanoparticles, ceria nanoparticles or nano-ceria (CeO-NPs). Their remarkable vacancy-oxygen defect (VO) facilitates the redox process and catalytic activity. The verification has illustrated that CeO-NPs, a nanozyme based on inorganic nanoparticles, can achieve the anti-inflammatory effect, cancer resistance, and angiogenesis. Also, they can well complement other materials in tissue engineering (TE). Pertinent to the properties of CeO-NPs and the pragmatic biosynthesis methods, this review will emphasize the recent application of CeO-NPs to orthopedic biomedicine, in particular, the bone tissue engineering (BTE). The presentation, assessment, and outlook of the orthopedic potential and shortcomings of CeO-NPs in this review expect to provide reference values for the future research and development of therapeutic agents based on CeO-NPs.
正在进行的生物医学纳米技术引起了人们对氧化铈纳米粒子、氧化铈纳米粒子或纳米氧化铈(CeO-NPs)越来越浓厚的兴趣。它们显著的空位-氧缺陷(VO)促进了氧化还原过程和催化活性。验证表明,CeO-NPs 作为一种基于无机纳米粒子的纳米酶,可实现抗炎、抗癌和血管生成的效果。此外,它们还可以很好地与组织工程(TE)中的其他材料互补。鉴于 CeO-NPs 的特性和实用的生物合成方法,本综述将重点介绍 CeO-NPs 在骨科生物医学中的最新应用,特别是在骨组织工程(BTE)中的应用。本综述对 CeO-NPs 在骨科方面的潜力和缺点进行了介绍、评估和展望,以期为基于 CeO-NPs 的治疗剂的未来研究和开发提供参考价值。